Table 3.
Factors | Disease-Free Survival | Overall Survival | ||
---|---|---|---|---|
HR (95% CI) | p value** | HR (95% CI) | p value** | |
Tumor status (1–2/3-4) | 7.159 (0.969–52.863) | 0.054 | 3.255 (0.769–13.768) | 0.109 |
Nodal status (0/1) | 0.910 (0.510–1.624) | 0.751 | 0.934 (0.515–1.694) | 0.822 |
Metastasis status (0/1) | 2.185 (1.224–3.898) | 0.008** | 2.091 (1.156–3.783) | 0.015** |
TNM stages(I–II/III–IV) | 7.381 (3.044–17.897) | <0.001** | 7.086 (2.923–17.178) | 0.006** |
PT (≥11.85/<11.85) | 2.361 (1.140–4.893) | 0.021** | 2.699 (1.333–5.463) | 0.006** |
PTA% (≥91.75/<91.75) | 1.173 (0.466–2.952) | 0.735 | 1.606 (0.629–4.103) | 0.322 |
INR (≥1.15/<1.15) | 1.277 (0.528–3.085) | 0.588 | 1.545 (0.631–3.782) | 0.341 |
APTT (≥25.85/<25.85) | 1.649 (0.987–2.755) | 0.046** | 1.942 (1.140–3.309) | 0.015** |
Fibrinogen (≥3.245/<3.245) | 1.240 (0.756–2.035) | 0.394 | 1.250 (0.760–2.056) | 0.380 |
Notes: **Cox proportional hazards model, p<0.05 considered as statistically significant. Bold values indicate significant differences (p<0.05).
Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval.